One‐week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies

To test the efficacy of omeprazole, furazolidone and amoxicillin triple therapy for the treatment of Helicobacter pylori infection after failure of standard first‐line therapy recommended by the Asia‐Pacific Consensus on the management of H. pylori infection.

[1]  C. Soussy,et al.  Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy , 2001, Alimentary pharmacology & therapeutics.

[2]  R. Malekzadeh,et al.  Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate , 2001, Alimentary pharmacology & therapeutics.

[3]  M. Yuen,et al.  One‐week ranitidine bismuth citrate‐based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance , 2001, Alimentary pharmacology & therapeutics.

[4]  Sd Xiao,et al.  A multicentre study on eradication of Helicobacter pylori using four 1‐week triple therapies in China , 2001, Alimentary pharmacology & therapeutics.

[5]  N. Leung.  Working towards a real cure for patients with small hepatocellular carcinoma , 2001, Journal of gastroenterology and hepatology.

[6]  G. Tytgat,et al.  A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine , 2000, Alimentary pharmacology & therapeutics.

[7]  W. Wong,et al.  13C‐urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese , 2000, Alimentary pharmacology & therapeutics.

[8]  Mukhopadhyay,et al.  High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong , 2000, Alimentary pharmacology & therapeutics.

[9]  K. Chu,et al.  One-week ranitidine bismuth citrate-based low dose clarithromycin triple therapy is superior to omeprazole-based regime for the eradication of Helicobacter pylori (H. Pylori) in Hong Kong with high prevalence of metronidazole resistance , 2000 .

[10]  Vahedi,et al.  Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease , 2000, Alimentary pharmacology & therapeutics.

[11]  L. van Doorn,et al.  Importance of Helicobacter pylori cagA and vacAstatus for the efficacy of antibiotic treatment , 2000, Gut.

[12]  Hoffman,et al.  Furazolidone combination therapies for Helicobacter pylori infection in the United States , 2000, Alimentary pharmacology & therapeutics.

[13]  F. Gomollón,et al.  Quadruple Therapy Is Effective for Eradicating Helicobacter pylori After Failure of Triple Proton‐Pump Inhibitor–Based Therapy: A Detailed, Prospective Analysis of 21 Consecutive Cases , 1999, Helicobacter.

[14]  R. Spiller,et al.  Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study , 1999, Antimicrobial Agents and Chemotherapy.

[15]  Gisbert,et al.  Seven‐day ‘rescue’ therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole , 1999, Alimentary pharmacology & therapeutics.

[16]  J. Gisbert,et al.  Re-treatment after Helicobacter pylori eradication failure. , 1999, European journal of gastroenterology & hepatology.

[17]  Hyde,et al.  Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practice , 1999, Alimentary pharmacology & therapeutics.

[18]  Xiao,et al.  High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week , 1999, Alimentary pharmacology & therapeutics.

[19]  Xiao,et al.  Furazolidone‐containing short‐term triple therapies are effective in the treatment of Helicobacter pylori infection , 1999, Alimentary pharmacology & therapeutics.

[20]  Lau,et al.  Triple therapy for Helicobacter pylori eradication is more effective than long‐term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long‐term follow‐up study , 1999, Alimentary pharmacology & therapeutics.

[21]  R. Spiller,et al.  The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. , 1999, Gastroenterology.

[22]  S. Lam,et al.  Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection , 1998, Journal of gastroenterology and hepatology.

[23]  C. O'Morain,et al.  Metronidazole Resistance Reduces Efficacy of Triple Therapy and Leads to Secondary Clarithromycin Resistance , 1997, Digestive Diseases and Sciences.

[24]  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. , 1997, Gut.

[25]  B. C. Wong,et al.  Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. , 1996, Gut.

[26]  R. Hopkins,et al.  Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. , 1996, Gastroenterology.

[27]  Jerome J. Schentag,et al.  In vitro selection of resistant Helicobacter pylori , 1990, Antimicrobial Agents and Chemotherapy.

[28]  G. Tytgat,et al.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori , 1990, The Lancet.

[29]  B. Marshall,et al.  PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI , 1988, The Lancet.

[30]  D. Forman,et al.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. , 1997, Gut.

[31]  S. Lam,et al.  Prevalence of metronidazole resistant Helicobacter pylori (Hp) strains among the Chinese peptic ulcer disease patients and normals in Hong Kong , 1995 .